What Are the Risks of Guillain-Barré Syndrome After SARS-CoV-2 Infection and COVID-19 Vaccination?

Neurology. 2023 Nov 14;101(20):875-876. doi: 10.1212/WNL.0000000000207998. Epub 2023 Oct 18.

Authors

Dennis Bourdette¹, Elizabeth Silbermann²

Affiliations

¹ From the Department of Neurology (D.B., E.S.), Oregon Health & Science University; and Department of Veterans Affair Medical Center (E.S.), Portland, OR. bourdett@ohsu.edu.
² From the Department of Neurology (D.B., E.S.), Oregon Health & Science University; and Department of Veterans Affair Medical Center (E.S.), Portland, OR.

PMID: 37852787
DOI: 10.1212/WNL.0000000000207998

No abstract available

Publication types

Editorial
Comment

MeSH terms

COVID-19 Vaccines* / adverse effects
COVID-19* / prevention & control
Guillain-Barre Syndrome* / epidemiology
Guillain-Barre Syndrome* / etiology
Humans
SARS-CoV-2
Vaccination / adverse effects

Substances

COVID-19 Vaccines